8:00 – 09:00
May 14th
Check in
9:00 – 9:30
May 14th
AstraZeneca Symposium
Mihnea Zdrenghea M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
IGHV status – the certainty in CLL genetics
9:30 – 9:50
May 14th
Novartis Symposium
Ioana Codruţa Rus M.D., PhD
Hematologist at „Ion Chiricuta” Oncological Institute Cluj-Napoca, Romania
Scemblix
9:50 – 10:20
May 14th
AstraZeneca Symposium
Ioana Codruţa Rus M.D., PhD
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca
PNH – a medical emergency
10:20 – 10:45
May 14th
Novartis Symposium
Alina Tanase, MD
Fundeni Clinical Institute, Bucharest. Romania
Jakavi
10:45 – 11:05
May 14th
Takeda Symposium
Tomuleasa Ciprian M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
The impact of prior treatment exposure on the effectiveness of NRd in patients with RRMM treated in routine clinical practice: A summary of the INSURE study
11:05 – 12:00
May 14th
Opening ceremony and Keynote Lecture
Aaron Ciechanover, MD, PhD
Technion Israel Institute of Technology, Haifa, Israel
Nobel Prize in Chemistry, 2004
12:00 – 12:30
May 14th
Coffee break + Q&A
12:30 – 13:00
May 14th
AbbVie Symposium
Horia Bumbea, M.D.
The Value of Bispecific antibodies in the treatment of DLBCL L3+
Hemophilia and Benign Hematology Session
12:55 – 13:00
May 14th
Roche Symposium
Welcome and Opening Remarks
Moderator: Ciprian Tomuleasa M.D. – Romania
13:00 – 13:30
May 14th
Expanding Horizons: The Latest Evidence on Emicizumab in Moderate Hemophilia A and Non-Inhibitor Patients
Johnny Mahlangu, M.D.
Charlotte Maxeke Johannesburg Academic Hospital at the University of the Witwatersrand and National Health Laboratory Service, Johannesburg, South Africa
13:30 – 13:40
May 14th
Clinical Insights and Shared Experiences
Johnny Mahlangu, M.D. (South Africa) & Emilia Ursu M.D. (Romania)
13:40 – 14:00
May 14th
Conclusions / Q&A
All
14:00 – 14:05
May 14th
Closing session
Ciprian Tomuleasa M.D.
14:05 – 15:00
May 14th
Lunch break
15:00 – 15:30
May 14th
Cedric Hermans, M.D.
Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
15:30 – 16:00
May 14th
Alok Srivastava MD, FRACP, FRCPA, FRCP
Christian Medical College Vellore, Tamil Nadu, India
Gene Therapy for Hemophilia – Progress and Challenges”
16:00 – 16:30
May 14th
Shruti Chaturvedi, MBBS, MS
Johns Hopkins University, Baltimore, USA
MPN / MD / AML session
16:30 – 17:30
May 14th
Swixx BioPharma Symposiums
Moderator: Mihnea Zdrenghea M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
Speakers:
Farhad Ravandi-Kashani, M.D.
University of Texas MD Anderson Cancer Center, Houston, USA
Bogdan Ionescu, MD
Fundeni Clinical Institute, Bucharest. Romania
17:30 – 18:00
May 14th
Curt I. Civin, MD
University of Maryland, Baltimore, USA
18:00 – 18:30
May 14th
Robert P Hasserjian, MD
Harvard Medical School, Massachusetts General Hospital, Boston, USA.
18:30 – 19:00
May 14th
Gabriel Ghiaur, MD, PhD
Johns Hopkins University, Baltimore, USA
